Clinical and demographic features of patients with moderate to severe active systemic lupus erythematosus in Russia - SEVERUS

Study identifier:D3461R00092

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

An observational multicenter retrospective-prospective study of patients with active moderate to severe SLE

Medical condition

Systemic Lupus Erythematosus

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

600

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 30 Sept 2024
Estimated Primary Completion Date: 30 Sept 2025
Estimated Study Completion Date: 30 Sept 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria